Table 3.
High-cost user status post-discharge for those with and without sepsis during hospitalization
| Variable | Unweighted | Weighted | ||||
|---|---|---|---|---|---|---|
| Sepsis | Non-Sepsis | Measure of Association | Sepsis | Non-Sepsis | Measure of Association | |
| Total cohort | ||||||
| N = 79, 065 | N = 847, 992 | N = 888,513 | N = 928,323 | |||
| Death during follow-up, n (%) | 30,158 (38.1%) | 127,925 (15.1%) | 25.60% | 16.41% | ||
| High-Cost User (Top 5%) for any 90-day period after discharge from hospital, n (%) | 35,419 (44.8%) | 201,533 (23.8%) | OR 2.60 (95% CI 2.56, 2.64) | 36.51% | 24.91% | OR 1.73 (95% CI 1.70, 1.77) |
| High-Cost User (Top 1%) for any 90-day period after discharge from hospital, n (%) | 10,082 (12.8%) | 40,282 (4.8%) | OR 2.93 (95% CI 2.86, 3.00) | 9.96% | 5.13% | OR 2.05 (95% CI 1.99, 2.11) |
| Proportion of follow-up time as a High-Cost User (Top 5%), Mean ± SD, Median (IQR) |
55.04% ± 39.22 52% (15–100) |
27.33% ± 33.18 12% (3–39) |
RR 2.01 (95% CI 2.01, 2.02) | 42.27% | 28.89% | RR 1.46 (95% CI 1.45, 1.48) |
| Proportion of follow-up time as a High-Cost User (Top 1%), Mean ± SD, Median (IQR) |
24.48 ± 33.11 8 (1–33) |
10.09 ± 22.33 2 (0–7) |
RR 2.43 (95% CI 2.42, 2.43) | 18.15% | 10.83% | RR 1.68 (95% CI 1.65, 1.70) |
| Total length of follow-up (days), Mean ± SD, Median (IQR) |
839.51 ± 437.37 934 (531 – 1,189) |
1,016.06 ± 342.51 1,063 (854 – 1,281) |
930.17 | 1006.42 | ||
| Previously in top 10% | ||||||
| N = 75, 105 | N = 782, 399 | N = 821,753 | N = 858,653 | |||
| High-Cost User (Top 5%) for any 90-day period after discharge from hospital, n (%) | 34,275 (45.6%) | 194,921 (24.9%) | OR 2.53 (95% CI 2.49, 2.57) | 37.62% | 26.07% | OR 1.71 (95% CI 1.68, 1.74) |
| High-Cost User (Top 1%) for any 90-day period after discharge from hospital, n (%) | 9,673 (12.9%) | 38,716 (4.9%) | OR 2.84 (95% CI 2.77, 2.91) | 10.14% | 5.33% | OR 2.00 (95% CI 1.94, 2.07) |
| Proportion of follow-up time as a High-Cost User (Top 5%), Mean ± SD, Median (IQR) |
56.40% ± 38.88 56% (17–100) |
28.78% ± 33.62 13% (4–43) |
RR 1.96 (95% CI 1.96, 1.96) | 43.94% | 30.37% | RR 1.45 (95% CI 1.44, 1.46) |
| Proportion of follow-up time as a High-Cost User (Top 1%), Mean ± SD, Median (IQR) |
25.04 ± 33.31 9 (2–35) |
10.62 ± 22.84 2 (0–8) |
RR 2.36 (95% CI 2.35, 2.36) | 18.8% | 11.38% | RR 1.65 (95% CI 1.63, 1.68) |
| Not previously in top 10% | ||||||
| N = 3, 960 | N = 65, 593 | N = 66,961 | N = 69,578 | |||
| High-Cost User (Top 5%) for any 90-day period after discharge from hospital, n (%) l | 1,144 (28.9%) | 6,612 (10.1%) | OR 3.62 (95% CI 3.37, 3.90) | 20.89% | 10.54% | OR 2.24 (95% CI 2.04, 2.46) |
| High-Cost User (Top 1%) for any 90-day period after discharge from hospital, n (%) | 409 (10.3%) | 1,566 (2.4%) | OR 4.71 (95% CI 4.20, 5.28) | 7.13% | 2.50% | OR 2.99 (95% CI 2.60, 3.45) |
| Proportion of follow-up time as a High-Cost User (Top 5%), Mean ± SD, Median (IQR) |
29.31% ± 36.79 10% (3–46) |
10.05% ± 20.71 3% (0–8) |
RR 2.92 (95% CI 2.90, 2.94) | 19.39% | 10.55% | RR 1.84 (95% CI 1.74, 1.94) |
| Proportion of follow-up time as a High-Cost User (Top 1%), Mean ± SD, Median (IQR) |
13.93 ± 26.96 3 (0–11) |
3.79 ± 13.48 0 (0–2) |
RR 3.68 (95% CI 3.64, 3.71) | 9.13% | 4.01% | RR 2.28 (95% CI 2.10, 2.48) |
OR Odds Ratio, RR Relative Rate, SD Standard Deviation, IQR Interquartile Range